Polymerase θ—what does it see, and why does it matter for cancer therapy?
NAR Cancer · 07.10.2025 · 7 (4)
DOI: 10.1093/narcan/zcaf042 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NAR Cancer, online erschienen am 06.11.2025. Verfasst von Dale A Ramsden und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive Cancer Center, University of North …. Hauptthemen laut MEDLINE: Neoplasms, DNA Repair, DNA-Directed DNA Polymerase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Polymerase theta (Pol θ) is a DNA repair factor that has drawn much recent interest as a target for cancer therapy, since its inhibition is well-tolerated in most cells but is lethal in cancers deficient in breast cancer-associated (BRCA) genes (“synthetic lethality”). Its normal biological functions, as well as how these functions change in BRCA-deficient cancers, are only recently becoming clear, however. We review here recent progress in our understanding of the cellular regulatory mechanisms at work in determining if Pol θ sees DNA damage. At the molecular scale Pol θ then must notably see and repair diverse classes of damage, including (at least) conventional double strand breaks (made by e.g. ionizing radiation), as well as several types of damage associated with replication stress. We speculate on the mechanisms that could explain this flexibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biophysics, Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
- Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
ORCID-Profile: Dale A Ramsden, Gaorav P Gupta
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Ramsden, D. A., & Gupta, G. P. (2025). Polymerase θ—what does it see, and why does it matter for cancer therapy?. NAR Cancer, 7(4). https://doi.org/10.1093/narcan/zcaf042
Vancouver
Ramsden DA, Gupta GP. Polymerase θ—what does it see, and why does it matter for cancer therapy?. NAR Cancer. 2025;7(4). doi:10.1093/narcan/zcaf042
BibTeX
@article{Ramsden2025,
author = {Ramsden, Dale A and Gupta, Gaorav P},
title = {Polymerase θ—what does it see, and why does it matter for cancer therapy?},
journal = {NAR Cancer},
year = {2025},
volume = {7},
number = {4},
doi = {10.1093/narcan/zcaf042}
}
EUVIMED